John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 10,800 shares at $7.42 ($80K) on 2022-05-16, disclosed to the SEC on 2022-05-18.
Open-market sale of $80k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |